Hengrui Pharmaceutical announced that recently, the company received a notice from the State Drug Administration to approve the addition of two additional indications for the Class 1 innovative drug Hetrapoethanolamine tablets independently developed by the company.

Zhitongcaijing · 2d ago
Hengrui Pharmaceutical announced that recently, the company received a notice from the State Drug Administration to approve the addition of two additional indications for the Class 1 innovative drug Hetrapoethanolamine tablets independently developed by the company.